Clinical Trial: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Study Status: Completed
Recruit Status: RECRUITING
Condition: Depressive Disorder
Study Type: INTERVENTIONAL
Official Title: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Brief Summary:
The purpose of this study is to test the hypothesis that the anti-depressant and anti-suicidal effects of the N-methyl-D-aspartate receptor (NMDAR) antagonist Ketamine is critically dependent on stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid receptors (AMPAR).
Read more